Medicare Enrolled

Dr. Shaheen Khosla, D.O.

Dermatology · Redwood City, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
100 ARCH ST STE 1, Redwood City, CA 94062
6504827546
In practice since 2008 (17 years)
NPI: 1649439720 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khosla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khosla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khosla

Dr. Shaheen Khosla is a dermatology specialist in Redwood City, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Khosla performed 919 Medicare services across 439 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khosla received a total of $6,709 from 37 pharmaceutical and/or device companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khosla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 919 Medicare services $6,709 industry payments

Medicare Practice Summary

Medicare Utilization ↗
919
Medicare services
Bottom 25% in CA for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
439
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
233 $7 $14
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
159 $83 $162
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
155 $115 $229
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
116 $116 $220
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
80 $98 $199
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
77 $52 $127
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
52 $1 $5
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
47 $93 $199
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,709
Total received (2018-2024)
Avg $958/year across 7 years
Top 23% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
253
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,709 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,398
2023
$1,220
2022
$489
2021
$667
2020
$914
2019
$897
2018
$1,124

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$682
Regeneron Healthcare Solutions, Inc.
$242
Biofrontera Inc.
$140
E.R. Squibb & Sons, L.L.C.
$138
GENZYME CORPORATION
$57
PFIZER INC.
$39
Novartis Pharmaceuticals Corporation
$32
Incyte Corporation
$26
REVANCE THERAPEUTICS, INC.
$22
Arcutis Biotherapeutics, Inc.
$20
Top 3 companies account for 76.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,029
Regeneron Healthcare Solutions, Inc.
$555
GENZYME CORPORATION
$391
Allergan, Inc.
$366
Galderma Laboratories, L.P.
$320
PFIZER INC.
$304
E.R. Squibb & Sons, L.L.C.
$284
Lilly USA, LLC
$278
LEO Pharma Inc.
$278
Janssen Scientific Affairs, LLC
$269
Ortho Dermatologics, a division of Bausch Health US, LLC
$237
Solta Medical, a division of Bausch Health US, LLC
$207
Novartis Pharmaceuticals Corporation
$191
Biofrontera Inc.
$188
Arcutis Biotherapeutics, Inc.
$188
VYNE Pharmaceuticals Inc.
$185
Celgene Corporation
$160
Allergan Inc.
$159
Amgen Inc.
$140
AbbVie, Inc.
$131
Merz North America, Inc.
$126
Neuronetics, Inc.
$111
Mayne Pharma Inc.
$105
Incyte Corporation
$101
Almirall LLC
$75
Sun Pharmaceutical Industries Inc.
$46
MERZ NORTH AMERICA, INC.
$45
AbbVie Inc.
$45
DUSA Pharmaceuticals, Inc.
$37
Janssen Biotech, Inc.
$26
DERMIRA, INC.
$24
Verrica Pharmaceuticals Inc.
$22
REVANCE THERAPEUTICS, INC.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
UCB, Inc.
$18
Taro Pharmaceuticals USA, Inc.
$16
Musculoskeletal Transplant Foundation Inc.
$9
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
0.25% · ADBRY · AMELUZ · AMZEEQ · BLU-U · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · COSENTYX · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · FINACEA · Finacea · Humira · ILUMYA · JUBLIA · LEVULAN KERASTICK · NEUROSTAR TMS THERAPY · ODOMZO · ONEXTON · OPZELURA · Otezla · QBREXZA · RINVOQ · SILIQ · SKYRIZI · Seysara · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · Tremfya · XEOMIN · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Redwood City?
Compare dermatologists in the Redwood City area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
252
Per 100K population
33.8
County median income
$156,000
Nearest hospital
SEQUOIA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khosla is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khosla experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Khosla performed 233 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khosla receive payments from pharmaceutical companies?
Yes. Dr. Khosla received a total of $6,709 from 37 companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khosla's costs compare to other dermatologists in Redwood City?
Dr. Khosla's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khosla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →